Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Methotrexate + Cytarabine + Thiotepa + Rituximab
MATRix
Routinely available
Local application
29/03/2023
Indication
Treatment of central nervous system lymphoma.
Therapeutic Area
Malignant disease and immunosuppression
Status Description
Routinely available in line with local guidance for prescribing
Formulation
-
Comments
-